2011. Recombinant factor VIIa is associated with an improved 24-hour survival without an improvement in inpatient survival in massively transfused civilian trauma patients . Clinics. 66, 1 (Jan. 2011), 101–106. DOI:https://doi.org/10.1590/S1807-59322011000100018.